SCHEMBL30746357

SCHEMBL30746357

CNS(=O)(=O)Nc1nccc(Cc2cncc(Nc3ccc(C(F)(F)F)cc3F)c2C)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 5/20 0.41
▸ MAP2K1 Q02750 5/20 0.41
▸ CYP2C9 P11712 2/20 0.40
▸ BRAF P15056 1/20 0.40
▸ MAP2K2 P36507 1/20 0.40
▸ MAP2K5 Q13163 1/20 0.40
▸ TRPV1 Q8NER1 8/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ MOGAT2 Q3SYC2 1/20 0.31
▸ CYP11B1 P15538 1/20 0.30
▸ CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26984970 1.00 RAF1 (0.41) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26984926 0.89 RAF1 (0.43) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL30746450 0.89 RAF1 (0.43) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26984961 0.88 RAF1 (0.42) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26985095 0.88 RAF1 (0.42) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL30746420 0.88 RAF1 (0.42) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL30746529 0.88 RAF1 (0.42) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26994668 0.87 RAF1 (0.44) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL30746504 0.87 MAP2K1 (0.41) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26984993 0.87 MAP2K1 (0.41) RAF1MAP2K1CYP2C9BRAFMAP2K2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback